Top Markets
Coin of the day
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Rank in Stocks #98
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Share Price
$37.45
Market Cap
$166.43B
Change (1 day)
-2.55%
Change (1 year)
-53.09%
Country
DK
Trade Novo Nordisk A/S (NVO)

Category

Stock split history for Novo Nordisk A/S (NVO)
Novo Nordisk A/S stock (symbol: NVO) underwent a total of 2 stock splits.
The most recent stock split occurred on Sep 13, 2023.
One NVO share bought prior to Jan 02, 2014 would equal to 10 NVO shares today.
Stock split list
Year Split Multiple Cumulative Multiple
2023-09-13 2:1 x2 x10
2014-01-02 5:1 x5 x5
Stock splits for similar companies or competitors
Company Number of stock splits Cumulative Multiple Country
1 x2
US
0 -
US
0 -
BE
1 x3
AU
0 -
NL